Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ault Glazer & Co. is a private investment management firm and family office headquartered in Miami, Florida, led by veteran investor Milton "Todd" Ault III. The firm specializes in identifying high-growth opportunities and providing strategic capital across diverse sectors, with a significant focus on the life sciences and biotechnology industries. Ault Glazer & Co. is notably instrumental in the financing and strategic oversight of Alzamend Neuro, a biopharmaceutical company dedicated to developing novel treatments for Alzheimer's disease and other neurodegenerative conditions. Through its affiliation with the diversified holding company Ault Alliance, the firm leverages a broad network of resources to support its portfolio companies from early-stage development through commercialization. The firm provides a range of services including venture capital, private equity, and wealth management advisory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ault Glazer & Co..